echoloc

PharmaResources Tech Stack

Small molecule CRO/CDMO with AI-driven drug discovery and process optimization

Research Services Shanghai 1,001–5,000 employees Founded 2007 Public Company

PharmaResources operates a vertically integrated CRO/CDMO business spanning compound design, process chemistry, and API manufacturing. The tech stack reveals dual engineering tracks: a computational chemistry layer (Python, PyMOL, RDKit, TensorFlow, PyTorch, Deepseek, Qwen, Llama) driving an active AI molecule generation project, paired with analytical chemistry instrumentation (HPLC, LC-MS) for method development and purification. The research-heavy hiring mix (29 of 47 active roles) and leadership roles focused on process R&D and synthesis teams signal scaling of internal capability rather than outsourced development.

Tech Stack 28 technologies

Core StackPython TensorFlow PyTorch RAG Linux NumPy Pandas scikit-learn Flask Django MySQL PostgreSQL MongoDB LangChain OpenAI HPLC LC-MS GCP Deepseek Qwen Llama PyMOL CUDA PyTorch Lightning RDKit GAN Streamlit LangGraph

What PharmaResources Is Building

Challenges

  • Optimizing performance system
  • R&d and production cost control
  • Building performance system from scratch
  • Expanding cro/cdmo business
  • Market development for innovative drugs
  • Technology transfer and commercialization
  • Ensure business continuity
  • Manage audit compliance
  • Technical challenges in nucleic acid drug development
  • Meeting project deadlines

Active Projects

  • Fluid chemistry process optimization
  • Ai molecule generation project
  • Del screening data analysis
  • Hplc/lcms method development for small nucleic acid purification
  • Performance system monitoring and tool optimization
  • Pharmacokinetic project
  • 药物合成工艺设计
  • 合成工艺优化
  • 工厂放大工艺转移
  • Establish information security policies

Hiring Activity

Decelerating45 roles · 15 in 30d

Department

Research
29
Engineering
6
Manufacturing
4
Sales
4
HR
3
Security
1

Seniority

Senior
16
Mid
14
Junior
7
Lead
4
Manager
4
Director
1
Intern
1

Notable leadership hires: Process R&D Director, Process R&D Lead, Synthesis Team Lead, Catalyst Lead

Company intelligence

Find more companies like PharmaResources by tech stack, pain points and active projects

Get started free

About PharmaResources

Founded in 2007, PharmaResources provides small molecule drug development and manufacturing services to global pharmaceutical companies. The business spans three verticals: drug discovery (compound screening and optimization), process research (synthesis innovation and scale-up), and API/intermediate production. The company operates from Shanghai with 1,001–5,000 employees, all hiring activity concentrated in China. Current projects span fluid chemistry optimization, nucleic acid purification methods, and factory-scale process transfers, while simultaneously advancing an AI molecule generation platform. Pain points center on technology transfer and commercialization, cost control in R&D and production, and meeting timelines as the CRO/CDMO business expands.

HeadquartersShanghai
Company Size1,001–5,000 employees
Founded2007
Hiring MarketsChina

Frequently Asked Questions

What is PharmaResources' tech stack?

PharmaResources uses HPLC, LC-MS, Python, GCP, PyMOL, RDKit, TensorFlow, PyTorch, and LangChain. They also employ LLMs (Deepseek, Qwen, Llama) and RAG for drug discovery workflows, plus standard web frameworks (Flask, Django) and data tools (NumPy, Pandas, scikit-learn).

Is PharmaResources hiring engineers?

Yes. PharmaResources has 6 active engineering roles (out of 47 total) with a mix of junior, mid, and senior levels. Hiring velocity is decelerating. All positions are based in China.

What is PharmaResources working on?

Active projects include AI molecule generation, fluid chemistry process optimization, HPLC/LC-MS method development for nucleic acid purification, pharmacokinetic studies, and factory-scale process transfers. The company is also establishing information security policies.

Similar Companies in Research Services

Other companies in the same industry, closest in size